Navigation Links
Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers
Date:12/13/2010

Cambridge, Mass., December 6, 2010 Utilizing a century-old phenomenon discovered in St. Paul's Cathedral, London, applied scientists at Harvard University have demonstrated, for the first time, highly collimated unidirectional microlasers.

The result of a collaboration with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, and the Institute of Theoretical Physics of the University of Magdeburg, Germany, the advance has a wide range of new applications in photonics such as sensing and communications.

Published online this week in the Proceedings of the National Academy of Sciences, the research team took advantage of a concept in physics referred to as "whispering gallery modes."

Over a century ago, British scientist Lord Rayleigh wondered how two people standing on opposite sides of the dome in St. Paul's Cathedral could hear each other by whispering into the circular wall. He discovered that the sound skirts along the smooth surface of the wall with negligible attenuation due to scattering or absorption.

The optical analog of whispers in a dome are light rays confined to the perimeter of tiny circular disks by multiple reflections from the boundary as they circle around. Because attenuation is minimal within the smooth disk, these resonators have already been used to make some of the world's lowest-threshold lasers. Circular disks, however, have posed certain challenges.

"One of the crucial unsolved problems of these microlasers for practical applications has been that their emission is non-directional and their optical power output is negligible," said team leader Federico Capasso, Robert L. Wallace Professor of Applied Physics and Vinton Hayes Senior Research Fellow in Electrical Engineering at Harvard's School of Engineering and Applied Sciences (SEAS).

"Light gets trapped by these whispering gallery modes with little chance to escape except by a faint isotropic emission. Strategies to suitably deform the disks to solve this problem have yielded disappointing results," Capasso added.

By shaping the microlaser as an ellipse with a wavelength-size notch carved out from its edge, Capasso's team found that the cycling whispering gallery modes scatter efficiently off the notch and emerge as nearly parallel beams from the microlaser.

The prototypes are quantum cascade lasers emitting an optical power of 5 milliwatts at a wavelength of 10 microns. The microlaser performance is insensitive to the details of the notch, making this device design very robust.

"Our calculations show that the notched elliptical microlaser should have even better performance at the shorter wavelengths near 1 micron, typical of laser diodes used in optical communications, where the attenuation of whispering gallery modes is negligible," said coauthor Jan Wiersig of the Institute of Theoretical Physics of the University of Magdeburg.

"The successful realization of these simple-structured and robust microlasers through standard wafer-based fabrication makes small-volume directional light sources possible for many important applications such as photonic integrated circuits with high-density chip-scale integration, optical communications, medical/biological sensors, and lab-on-a-chip," said coauthor Masamichi Yamanishi, Research Fellow of Central Research Laboratories at Hamamatsu.


'/>"/>

Contact: Caroline Perry
cperry@seas.harvard.edu
617-496-1351
Harvard University
Source:Eurekalert  

Related biology technology :

1. Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis
2. Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema
3. Molecular Detections Detect-Ready™ MRSA Assay Demonstrates Strong Performance In Independent Comparative Study From Leading UK Hospital
4. Newly Published Caldolor® Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients
5. Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients
6. New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
7. New Study Demonstrates Clinical Validity of EarlyCDT-Lung™
8. Æterna Zentaris: Publication in the Journal of the National Cancer Institute Demonstrates Perifosine Single Agent Potential in Neuroblastoma Tumors
9. New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy
10. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
11. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: ... personalized immune therapies for operable and inoperable solid tumor ... Chief Technical Officer of NW Bio, will present at ... 2017, at the Hyatt Regency Hotel in ... chair the session entitled "New Therapeutic Approaches – Expanding ...
(Date:1/18/2017)... India , January 18, 2017 According to a ... (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic ... is expected to reach USD 739.9 Million by 2021 from USD 557.1 Million ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
Breaking Biology News(10 mins):